$750 | Single User
$1500 | Site License
$2250 | Global License

Clinical Laserthermia Systems AB (CLS B) - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018]

Published by Global Data: 27 Dec 2018 | 228662 | In Stock

Introduction

Summary

Clinical Laserthermia Systems AB (CLS) develops and markets systems and single-use instruments for the treatment of solid cancer tumors. The company's flagship product TRANBERG, a cancer immunotherapy system consists of a mobile laser unit and single-use products developed to perform a precise and safe treatment. It also comprises a laser applicator with introducer that is used for positioning of the fiber, depending on the tumor size. TRANBERG is developed for immune stimulating interstitial thermotherapy (imILT). CLS is also evaluating its products for treating focal laser ablation and other combined therapies. The company offers its products to hospitals and clinics. CLS is headquartered Lund, Sweden.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Clinical Laserthermia Systems AB

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for Clinical Laserthermia Systems AB (CLS B) - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018]

  • Table of Contents

    Table of Contents 2

    List of Tables 4

    List of Figures 4

    Clinical Laserthermia Systems AB Company Overview 5

    Clinical Laserthermia Systems AB Company Snapshot 5

    Clinical Laserthermia Systems AB Pipeline Products and Ongoing Clinical Trials Overview 5

    Clinical Laserthermia Systems AB – Pipeline Analysis Overview 8

    Business Description 8

    Clinical Laserthermia Systems AB - Key Facts 8

    Clinical Laserthermia Systems AB - Major Products and Services 9

    Clinical Laserthermia Systems AB Pipeline Products by Development Stage 10

    Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status 14

    Clinical Laserthermia Systems AB Pipeline Products Overview 16

    CLS Cancer Immunotherapy System - Prostate Cancer 16

    CLS Cancer Immunotherapy System - Prostate Cancer Product Overview 16

    CLS Cancer Immunotherapy System - Prostate Cancer Clinical Trial 17

    imILT Software 18

    imILT Software Product Overview 18

    imILT Software Clinical Trial 19

    TRANBERG Cancer Immunotherapy System - Breast Cancer 20

    TRANBERG Cancer Immunotherapy System - Breast Cancer Product Overview 20

    TRANBERG Cancer Immunotherapy System - Breast Cancer Clinical Trial 21

    TRANBERG Cancer Immunotherapy System - Pancreatic Cancer 22

    TRANBERG Cancer Immunotherapy System - Pancreatic Cancer Product Overview 22

    TRANBERG Cancer Immunotherapy System - Pancreatic Cancer Clinical Trial 23

    TRANBERG Cancer Immunotherapy System - Skin Cancer 24

    TRANBERG Cancer Immunotherapy System - Skin Cancer Product Overview 24

    TRANBERG Cancer Immunotherapy System - Solid Cancers 25

    TRANBERG Cancer Immunotherapy System - Solid Cancers Product Overview 25

    TRANBERG Cancer Immunotherapy System - Solid Cancers Clinical Trial 26

    Clinical Laserthermia Systems AB - Key Competitors 27

    Clinical Laserthermia Systems AB - Key Employees 28

    Clinical Laserthermia Systems AB - Key Employee Biographies 29

    Clinical Laserthermia Systems AB - Locations And Subsidiaries 30

    Head Office 30

    Other Locations & Subsidiaries 30

    Recent Developments 31

    Clinical Laserthermia Systems AB, Recent Developments 31

    Jun 18, 2018: CLS receives new order for single use products from UTMB in the U.S., for treatment of early stage prostate cancer 31

    Apr 19, 2018: First patients treated with CLS TRANBERG-system in the clinical study at Toronto General Hospital, Canada 31

    Apr 19, 2018: CLS participates with hands-on workshop at the European Conference on Interventional Oncology 31

    Apr 17, 2018: Clinical Laserthermia Systems and Toronto General Hospital Begin Clinical Study for MRI-Guided Laser Ablation Treatment of Prostate Cancer 32

    Apr 11, 2018: Clinical Laserthermia Systems Exhibits MRI-Guided Laser Ablation System at Southwest Prostate Cancer Symposium 32

    Apr 04, 2018: CLS quality processes received good marks by American authority FDA 32

    Mar 16, 2018: CLS and Toronto General Hospital, Canada, carry out clinical study regarding MRI guided FLA treatment of prostate cancer 33

    Mar 14, 2018: CLS receives new order for the TRANBERG-system from UTMB in the U.S. 33

    Mar 08, 2018: CLS imILT treatment of pancreatic cancer shows positive trend regarding survival 33

    Jan 02, 2018: CLS single use accessories evaluated by Laser Prostate Centers of America 34

    Appendix 35

    Methodology 35

    About GlobalData 38

    Contact Us 38

    Disclaimer 38

List Of Tables
in Clinical Laserthermia Systems AB (CLS B) - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018]

List of Tables

Clinical Laserthermia Systems AB Pipeline Products and Ongoing Clinical Trials Overview 5

Clinical Laserthermia Systems AB Pipeline Products by Equipment Type 6

Clinical Laserthermia Systems AB Pipeline Products by Indication 7

Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status 7

Clinical Laserthermia Systems AB, Key Facts 8

Clinical Laserthermia Systems AB, Major Products and Services 9

Clinical Laserthermia Systems AB Number of Pipeline Products by Development Stage 10

Clinical Laserthermia Systems AB Pipeline Products Summary by Development Stage 11

Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status 14

Clinical Laserthermia Systems AB Ongoing Clinical Trials Summary 15

CLS Cancer Immunotherapy System - Prostate Cancer - Product Status 16

CLS Cancer Immunotherapy System - Prostate Cancer - Product Description 16

CLS Cancer Immunotherapy System - Prostate Cancer - Exploratory Study on Immunostimulating Interstitial Laser Thermotherapy in Malignant Melanoma 17

CLS Cancer Immunotherapy System - Prostate Cancer - Immunostimulating Interstitial Laser Thermotherapy in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective, Open, Non Comparative Study 17

imILT Software - Product Status 18

imILT Software - Product Description 18

imILT Software - Immunostimulating Interstitial Laser Thermotherapy in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective, Open, Non Comparative Study 19

TRANBERG Cancer Immunotherapy System - Breast Cancer - Product Status 20

TRANBERG Cancer Immunotherapy System - Breast Cancer - Product Description 20

TRANBERG Cancer Immunotherapy System - Breast Cancer - Interstitial Laser Thermotherapy (imILT) as a Treatment option in Breast Cancer Patients not suitable for Surgical Excision 21

TRANBERG Cancer Immunotherapy System - Pancreatic Cancer - Product Status 22

TRANBERG Cancer Immunotherapy System - Pancreatic Cancer - Product Description 22

TRANBERG Cancer Immunotherapy System - Pancreatic Cancer - An Open-label, Comparative Trial to Evaluate the Effect of imILT in Patients with Advanced Disease or Stage IV Pancreatic Carcinoma 23

TRANBERG Cancer Immunotherapy System - Pancreatic Cancer - Prospective, Open, Non Comparative Trial to Evaluate Safety and Feasibility of Immunostimulating Interstitial Laser Thermotherapy (imILT) in Stage III Pancreatic Carcinoma 23

TRANBERG Cancer Immunotherapy System - Skin Cancer - Product Status 24

TRANBERG Cancer Immunotherapy System - Skin Cancer - Product Description 24

TRANBERG Cancer Immunotherapy System - Solid Cancers - Product Status 25

TRANBERG Cancer Immunotherapy System - Solid Cancers - Product Description 25

TRANBERG Cancer Immunotherapy System - Solid Cancers - To Evaluate the Safety and Palliative Treatment Effect on Patients with Solid Cancers by Immunostimulating Interstitial Laser Thermotherapy (imILT) 26

Clinical Laserthermia Systems AB, Key Employees 28

Clinical Laserthermia Systems AB, Key Employee Biographies 29

Clinical Laserthermia Systems AB, Subsidiaries 30

Glossary 37

List Of Figures, Charts and Diagrams
in Clinical Laserthermia Systems AB (CLS B) - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018]

List of Figures

Clinical Laserthermia Systems AB Pipeline Products by Equipment Type 6

Clinical Laserthermia Systems AB Pipeline Products by Development Stage 10

Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status 14

Additional Details

Publisher

Global Data

Publisher Information

Reference

228662 | GDME258622PD

Number of Pages

38

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2010-2016
The Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2010- 2016 report pr...
01 Oct 2016 by Current Partnering USD $2,995 More Info
Sogo Clinical Holdings Co., Ltd. (2399) - Financial and Strategic SWOT Analysis Review
SummarySogo Clinical Holdings Co., Ltd. (Sogo) is a site management organization that provides suppo...
09 Jan 2016 by Global Data USD $300 More Info
Sapporo Clinical Laboratory Inc. (9776) - Financial and Strategic SWOT Analysis Review
SummarySapporo Clinical Laboratory Inc. (Sapporo) is a clinical laboratory testing service provider ...
09 Jan 2016 by Global Data USD $300 More Info
Sogo Clinical Holdings Co., Ltd. (2399) - Financial and Strategic SWOT Analysis Review
SummarySogo Clinical Holdings Co., Ltd. (Sogo) is a site management organization. The company provid...
08 Nov 2015 by Global Data USD $300 More Info
Sapporo Clinical Laboratory Inc. (9776) - Financial and Strategic SWOT Analysis Review
SummarySapporo Clinical Laboratory Inc. (Sapporo) is a clinical laboratory testing service provider ...
08 Nov 2015 by Global Data USD $300 More Info
Enzo Clinical Labs, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryEnzo Clinical Labs, Inc. (Enzo Clinical), a subsidiary of Enzo Biochem, Inc. is a clinical re...
16 Oct 2015 by Global Data USD $250 More Info
Clinical Trial Design for Commercial Success
IntroductionClinical Trial Design for Commercial Success offers expert insights on how to best posit...
01 Jun 2015 by FirstWord Pharma USD $695 More Info
Designing Clinical Trials to Show Value
IntroductionOnce, they were the benchmark for product development. But these days, randomised contro...
01 Jan 2014 by FirstWord Pharma USD $695 More Info
The Path to Product Inclusion in Clinical Guidelines: Strategies for Success
IntroductionClinical guidelines are taking hold in the practice of medicine. Though not always volun...
01 Feb 2013 by FirstWord Pharma USD $695 More Info
Tapping Social Media for Clinical Trial Recruitment
IntroductionWith an estimated 80% of all clinical trials failing to achieve enrolment goals, sponsor...
01 Apr 2012 by FirstWord Pharma USD $695 More Info

This report is published by Global Data

Download Free Report Summary PDF

Clinical Laserthermia Systems AB (CLS B) - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data